DEVELOPMENT OF CANINE IMMUNOTHERAPY TARGETED AGENTS — VICKIE COLEMAN (LEIDOS BIOMEDICAL RESEARCH, INC.)
The Division of Cancer Treatment and Diagnosis, NCI is requesting support for the development and production of canine-specific agonists and/or antagonist antibodies to support immunotherapy studies i
| Project title | DEVELOPMENT OF CANINE IMMUNOTHERAPY TARGETED AGENTS |
|---|---|
| Project number | 75N91019D00024-0-759102100016-1 |
| PI name | VICKIE COLEMAN |
| Institution | LEIDOS BIOMEDICAL RESEARCH, INC. |
| Funding mechanism | N01 |
| Agency | NCI |
| Award amount | $6.46M |
| Fiscal year | 2021 |
| Project start | 2021-09-16T00:00:00 |
| Project end | 2025-09-15T00:00:00 |
| Abstract | The Division of Cancer Treatment and Diagnosis, NCI is requesting support for the development and production of canine-specific agonists and/or antagonist antibodies to support immunotherapy studies i |
| Key terms | <Agonist><Antibodies><Canine Species><Canis familiaris><Companions><Development><Division of Cancer |
$799/mo
Try GrantRadar →